1.
Bjorkholm M, Fagrell B, Przybelski R, Winslow N, Young M, Winslow R. A phase I single blind clinical trial of a new oxygen transport agent (MP4), human hemoglobin modified with maleimide-activated polyethylene glycol. Haematologica 2005; 90(4):505-515.